Patents by Inventor Keith Rushlow

Keith Rushlow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070218565
    Abstract: The present invention includes a method to detect IgE using a human Fc epsilon receptor (Fc?R) to detect IgE antibodies in a biological sample from a cat, a dog, or a horse. The present invention also relates to kits to perform such methods.
    Type: Application
    Filed: March 8, 2007
    Publication date: September 20, 2007
    Inventors: Glenn Frank, James Porter, Keith Rushlow, Donald Wassom
  • Publication number: 20060099659
    Abstract: The present invention includes a method to detect IgE using a human Fc epsilon receptor (Fc?R) to detect IgE antibodies in a biological sample from a cat, a dog, or a horse. The present invention also relates to kits to perform such methods.
    Type: Application
    Filed: December 16, 2005
    Publication date: May 11, 2006
    Inventors: Glenn Frank, James Porter, Keith Rushlow, Donald Wassom
  • Publication number: 20060034944
    Abstract: Disclosed are compositions and corresponding methods for treating fibrocystic breast disease or other breast-related disease or condition. The compositions comprise, per serving or dose, from zero to about 400 ?g selenium, from about 100 mg to about 6000 mg gamma linolenic acid, and about 0.15 mg to about 5 mg iodine, with nutritional embodiments further comprising one or more of protein, fat, carbohydrate, vitamins, and minerals and providing from about 50 to about 1000 kcal of energy per severing or dose. Also disclosed are in-vitro studies showing that certain combinations of gamma linolenic acid, iodine, and/or selenium may 1) inhibit breast cancer or fibrocystic cell proliferation, 2) reinforce the function of tight junctions of endothelial cells and of mammary epithelial cells in estrogen-sensitive conditions, and 3) reduce the risk of vascular invasion by breast cancer cells.
    Type: Application
    Filed: April 28, 2005
    Publication date: February 16, 2006
    Inventors: Keith Rushlow, Robert Shalwitz, Terrence Mazer, Normanella Dewille, Tapas Das, Anand Seth